BMKS3.SA $328.04 -4.9159%
BSFC $0.11 -3.3621%
8052.HK $0.02 -6.25%
SDV.L $172.00 0%
1107.HK $0.11 0%
NVVEW $0.08 -4.7619%
HEWC $30.79 -0.1126%
8621.HK $0.03 0%
DWAW $30.08 0.0333%
SGMS $58.07 0%
P34.SI $1.29 2.381%
0099.HK $1.72 1.1765%
STKS $6.87 0.5857%
THCBW $3.03 0%
BFK $9.86 -0.0963%
1776.HK $11.98 -0.3328%
MBTCR $0.11 -0.0009%
TING.L $107.18 0.3302%
HMJD.L $34.85 1.1464%
MLNEI.PA $1.75 0%
ONCY $1.61 0%
ALTRO.PA $4.02 0%
SHOP $61.27 -2.5914%
IWV $234.19 -0.6967%
0P00017UWM.L $13 993.00 0.296%
TRE.MC $8.71 4.1268%
LEN $112.66 -1.1798%
ENVX $12.53 -1.5711%
DASH $65.39 -2.7298%
BTAQ $10.04 0%
CPH2.L $26.25 -6.25%
LIN.PA $46.10 0%
POWRU $10.16 0%
JSMD $56.00 -0.5645%
9979.HK $7.10 -0.9763%
0HVB.L $67.30 0.2906%
HSP.L $387.50 -0.641%
INCO.BR $30.71 0%
EAR $4.86 -8.818%
GTLY.L $172.00 0%
JOB $0.50 1.0204%
DIAX $14.36 -0.6916%
COOLU $10.12 0%
BML-PG $20.23 0.8801%
AMAO $10.22 0.002%
TNET $91.39 2.9051%
0899.HK $0.15 0%
UTL.L $145.50 0.692%
0QPH.L $0.14 15.2954%
SAG.L $406.50 0.1232%
1606.HK $1.09 0.9259%
0HS2.L $200.69 0.2278%
SMMT $1.79 -7.2727%
IUQA.L $10.18 -0.0246%
ULST $40.24 0.0729%
3992.HK $1.44 0%
DPT.PA $0.13 0%
CORR4.SA $82.00 0%
GFHG.L $1.75 -41.6667%
SWSSU $10.59 0%
CW8G.L $34 740.00 0.0648%
LXEH $0.54 -2.8923%
DEV.L $30.00 0%
HCNE $10.22 -0.0489%
LESG.L $14.30 0%
8152.HK $0.05 0%
0057.HK $1.76 -1.1236%
CTBI $33.21 -0.1203%
HCP $31.21 -3.0745%
CNUA.L $9 764.50 -1.5328%
ALADA.PA $18.00 0%
MFX.L $25.90 3.6%
HFWA $15.11 -2.1063%
ACTV $28.41 -0.5987%
SPFR-UN $8.90 0%
6858.HK $3.29 0.9202%
LSXMB $26.18 0%
MRACW $1.44 0%
DLR $96.46 -1.3399%
BWCU.SI $0.30 1.7241%
IBB $129.53 -0.69%
RGNX $18.92 -1.4583%
DWHT.L $1 079.00 0.3721%
FTVIU $10.10 0%
TBC $24.83 0%
OBSV $0.10 0%
7348.HK $9.00 1.1811%
1766.HK $4.69 -3.0992%
UBT $26.11 -1.2481%
2368.HK $4.43 0%
NICL.L $1 040.00 0.4831%
GPMT-PA $15.86 0%
LNTH $98.89 -0.4931%
AQMS $1.05 2.1359%
0K87.L $28.51 -0.7036%
0K79.L $74.17 0.6117%
0QLX.L $1 794.82 -0.6702%
CSFS.L $6.89 -2.993%
DVN $47.02 -0.5078%
Eng
Логотип
Eng
Лого

Sartorius Stedim Biotech S.A. DIM.PA

$246.30

+$2.73 (1.11%)
На 18:01, 12 мая 2023

Ранг: 2

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    22663176780.00000000

  • week52high

    400.00

  • week52low

    229.60

  • Revenue

    3492700000

  • P/E TTM

    27

  • Beta

    0.45496100

  • EPS

    9.27000000

  • Last Dividend

    1.44000000

  • Next Earnings Date

    21 июл 2023 г. в 05:00

Описание компании

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.
Grading company New grade Previous grade Recommendation date
Societe Generale Hold Buy 01 окт 2021 г.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек